Reuters logo
BRIEF-Progenics announces $50 million RELISTOR royalty-backed financing
November 7, 2016 / 1:13 PM / a year ago

BRIEF-Progenics announces $50 million RELISTOR royalty-backed financing

Nov 7 (Reuters) - Progenics Pharmaceuticals Inc

* Progenics announces $50 million RELISTOR royalty-backed financing

* Progenics Pharmaceuticals says MNTX Royalties Sub LLC entered into $50 million term loan agreement with a fund managed by Healthcare Royalty Partners

* Progenics Pharmaceuticals says lenders have no recourse to co or to any of its assets other than RELISTOR royalty rights Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below